In addition, the TMB of samples with MSH2 and MSH6 germline variants in this group was lower than that in the other two groups, and the TMB of PMS2 germline variant samples in this group was lower than that in the non-CNS LS-related tumor group. This evidence concerns the gene MSH2 and neoplasm.